2026年1月12日至16日医疗科技股涨跌榜
Med-tech gainers and losers for Jan. 12-16, 2026
生物技术与制药领域的最新动态
Med-tech gainers and losers for Jan. 12-16, 2026
Regulatory actions for Jan. 20, 2026
Six drugs to watch in China for 2026
December blockbusters push biopharma deal value to record high
Early data lift Immunofoco’s solid tumor CAR T program
Holiday notice
Biggest gainers and losers for Jan. 12-16, 2026
Sundance Biosciences patents new TYK2 inhibitors for multiple sclerosis
University of Washington discovers HER2-targeting ADCs for cancer
Daewoong Pharmaceutical patents divulge new IRAK-4 inhibitors
Zincure synthesizes new MMP-9 inhibitors
Chong Kun Dang Pharmaceutical discovers new GLP-1R agonists
Negio Therapeutics patents α2-adrenoceptor agonists
Nanjing Chia Tai Tianqing Pharmaceutical identifies new somatostatin SST2 receptor agonists
Shenzhen Newrosetta Biosciences discloses new muscarinic M2 receptor antagonists
Immunitybio’s CAR-NK shows complete responses in Waldenström’s
New review finds no evidence Tylenol in pregnancy raises autism risk
Financings for Jan. 16, 2026
In the clinic for Jan. 16, 2026
Other news to note for Jan. 16, 2026